Soliris IV infusion 300mg, from Alexion Pharma, contains Eculizumab (genetically recombinant). This injectable drug (YJ code: 6399424A1023) is provided as 300mg in 30mL per bottle and is indicated for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD).
Soliris IV infusion 300mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).